SkinBioTherapeutics PLC
Interim Report: Who cares! Revolutionary Journey of SkinBiotix™ to Commercial Triumph in 2024
By Elric Langton & Alex Langton | 22 March 2024
Mike, Alex and Elric have a financial interest in SkinBioTherapeutics.
Be honest, did you read the RNS from SkinBioTherapeutics with the odd grown of discontent? We both did, but there are very subtle clues, and you know we love a clue to investigate. We did, and as you will read, we are quite excited. The journey from conceptualisation to market launch is intricate and fraught with anticipation in cosmetic science and commercialisation. Such is the case with SkinBioTherapeutics and its promising venture with Croda/Sederma concerning the SkinBiotix lysate which we understand will commercially launch later this year.